Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype
Manfredi Rizzo(University of Palermo), Enrico Carmina(OHB (Italy)), Kaspar Berneis, Ilenia Pepe(University of Palermo), Gaetana Di Fede(University of Palermo), Giovam Battista Rini(University of Palermo), Giatgen A. Spinas(Core Laboratories (United States)), Martin Hersberger(University Children's Hospital Zurich)
Cited by 99
Related Papers
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
|Fertility and Sterility|2011|2k
Polycystic ovary syndrome
|Nature Reviews Disease Primers|2016|1.9k
Complications of Diabetes 2017
|Journal of Diabetes Research|2018|644
American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
|Endocrine Practice|2015|628
Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women
|The Journal of Clinical Endocrinology & Metabolism|1999|508